ST
Shattuck Labs, Inc.
STTK · NASDAQ
$6.79 -0.73% (-$0.05)
1M -6.60%
Market Cap $629.0M
P/E Ratio -
Div. Yield -
ROE 43.57%
Piotroski F-Score Weak
2/9Valuation
34 /100
Fair P/B 2.98x
P/S 628.99x
EV/EBITDA N/A
Growth
69 /100
Growing Book val. growth 22.38%
Rev. growth 15.32%
FCF growth N/A
Profitability
0 /100
Weak Net margin 5,256.80%
Op. margin 5,578.70%
FCF margin 4,124.00%
Quality
0 /100
Poor ROE 43.57%
ROA 23.82%
Asset turnover 0.00x
Debt
100 /100
Low Current ratio 27.59x
Debt/Equity 0.01x
Net debt/EBITDA N/A
Stability
46 /100
Moderate Rev. volatility 169.19%
EPS volatility 19.43%
Profitable years 0
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na STTK
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Taylor H. Schreiber
Employees
40
Headquarters
Austin
Nadcházející události
10 LIS
Earnings
Upcoming earnings report